Li Meng has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Li Meng is identified in the most recent SEC filing dated 2026-07-13 as the Interim Chief Executive Officer of Avalon GloboCare Corp. The publicly reported information available from the SEC filing indicates Li Meng held an interim executive leadership role at Avalon GloboCare during that period; further publicly available background information about Li Meng is limited. Avalon GloboCare Corp is a biotechnology company focused on cell therapy and related diagnostics, and Li Meng’s interim tenure suggests a transitional leadership phase for the company at that time.
Role
Interim CEO
Notability
20/100
Board memberships
Avalon GloboCare Corp.
Awards & honors
Appointed Interim CEO of Avalon GloboCare Corp. as of 2026-07-13 per SEC filing
Li Meng is identified in the most recent SEC filing dated 2026-07-13 as the Interim Chief Executive Officer of Avalon GloboCare Corp. The publicly reported information available from the SEC filing indicates Li Meng held an interim executive leadership role at Avalon GloboCare during that period; further publicly available background information about Li Meng is limited. Avalon…
How many SEC Form 4 filings has Li Meng submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Li Meng's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
